|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan
2 Kagome Research Institute, Tochigi, Japan
* To whom correspondence should be addressed. E-mail: kseyama{at}med.juntendo.ac.jp.
The senescence-accelerated mouse (SAM) is a naturally occurring animal model for accelerated aging after normal development and maturation. SAMP1 strain was reported to show age-related structural and functional changes in lung and be a murine model of senile lung. We postulated that aging of lung is an important intrinsic process for the development of emphysema and even in a short period of tobacco-smoke exposure may be able to generate emphysema. At age of 12 weeks, SAMP1 inhaled air or 1.5% tobacco smoke (TPM 23.9 mg/m3) through the nose for 30 min per day, 5 days per week, and for 8 weeks. The mean liner intercepts (MLI) and destructive index (DI) of the lung were significantly increased (air vs. smoke (mean±SEM); MLI, 68.76±0.69 vs. 75.34±1.70 µm, p<0.05 and DI, 8.61±0.38 vs. 16.18±1.54 %, p<0.05) whereas no significant changes observed in SAMR1, control mice that shows normal aging. In contrast, smoke-induced emphysema was completely prevented by concomitant ingestion of lycopene (a potent antioxidant) given as tomato juice, (MLI: smoke with or without lycopene (mean±SEM), 62.87±0.8 vs. 66.90±1.33µm, p<0.05). Smoke exposure increased apoptosis and active caspase-3 of airway and alveolar septal cells and reduced VEGF in lung tissues, but tomato juice ingestion significantly reduced apoptosis and increased tissue VEGF level. We concluded that SAMP1 is a useful model for tobacco-smoke induced emphysema and a valuable tool to explore both pathophysiologic mechanisms and the effect of therapeutic intervention on smoke-induced emphysema.
This article has been cited by other articles:
![]() |
I Petrache, K Diab, K S Knox, H L Twigg III, R S Stephens, S Flores, and R M Tuder HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism Thorax, May 1, 2008; 63(5): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mori, T. Nose, K. Ishitani, S. Kasagi, S. Souma, T. Akiyoshi, Y. Kodama, T. Mori, M. Kondo, S. Sasaki, et al. Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L196 - L204. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshida and R. M. Tuder Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Physiol Rev, July 1, 2007; 87(3): 1047 - 1082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |